1-4 of 4
Gregory R Bociek
Close
Sort by
Journal Articles

Understanding the Treatment Preferences of Adults with Cancer

Prajwal Dhakal, Christopher Wichman, Bunny Pozehl, Meaghann S. Weaver, Alfred L. Fisher, Julie M. Vose, Gregory R. Bociek, Vijaya Raj Bhatt
Journal: Blood
Blood (2022) 140 (Supplement 1): 5070–5072.
https://doi.org/10.1182/blood-2022-164863
Published: 2022
Journal Articles

BET Inhibition As a Targeted Epigenetic Approach to Reverse T Cell Dysfunction in Chronic Lymphocytic Leukemia

Audrey L Smith, Alexandria P Eiken, Sydney A Skupa, Dalia Y Moore, Avyakta Kallam, Christopher D'Angelo, Gregory R Bociek, Matthew A. Lunning, Julie M. Vose, Ben Powell, Gideon Bollag, Dalia ElGamal
Journal: Blood
Blood (2021) 138 (Supplement 1): 3715.
https://doi.org/10.1182/blood-2021-153921
Published: 2021
Journal Articles

Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression.

Avadhut D. Joshi, B.Pharm, John D. Dickinson, PhD, James C. Lynch, PhD, Philip J. Bierman, MD, Gregory R. Bociek, MD, Marcel P. Devetten, MD, James O. Armitage, MD, Shantaram S. Joshi, PhD
Journal: Blood
Blood (2005) 106 (11): 2103.
https://doi.org/10.1182/blood.V106.11.2103.2103
Published: 2005
Journal Articles

Anticoagulant Therapy for the Treatment of Idiopathic Osteonecrosis.

Saaib Al Shehadat, MD, Gregory R. Bociek, MD, William Haire, MD
Journal: Blood
Blood (2005) 106 (11): 919.
https://doi.org/10.1182/blood.V106.11.919.919
Published: 2005